Differentiating FSO and FSP approaches can better align definitions of models for CROs and sponsors.
Dr. Mark Travers
Advertisement
VP, Head of GCTO Regions and Head Quarters Functions at Merck & Co
Articles by Dr. Mark Travers
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Approves Oral Wegovy Following Positive Phase III OASIS 4 Trial Results
2
FDA Approves Subcutaneous Lunsumio VELO Based on GO29781 Trial Results in Relapsed or Refractory Follicular Lymphoma
3
Our Top 5 Most Read Articles in 2025
4
Controlled Clinical Trials in Sub-Saharan Africa: A Winning Value Proposition
5